Cytodyn Inc (CYDY)

[Inoviorulez]

Ibalizumab is close on intravenous administration for HIV. That means once approved patients will have to go to the hospital twice a month and stay there for a few hours to get intravenous administration. Ibalizumab is not even close to self injection like PRO 140. Matter of fact I don't even believe they are yet in a phase 2 trial for self injection. I will have to go back and look that up.

PRO 140 will be leaps and bounds ahead anyways even if it comes out later. Patients will want to do their treatment at home, very quick. Who wants t hassle traveling to the hospital every time you need treatment? Nice try on the Ibalizumb argument but maybe next time try harder.